New mRNA Flu Vaccine: What to Know About FDA Approval
The U.S. Food and Drug Administration approved Moderna’s mFLUSIVA on August 5, marking the first influenza vaccine to use mRNA technology for adults aged 50 and older. Clinical trials demonstrate ... Read More